Healthcare >> CEO Interviews >> May 3, 2004
DR. LEN JACOB has served as Chairman of the Board of Directors and Chief
Executive Officer of InKine Pharmaceutical Company, Inc., since November
1997. Prior to joining the company, Dr. Jacob served as the President
and Chief Executive Officer of Sangen Pharmaceutical Company and as a
consultant to various biotechnology companies from June 1996. From 1989
to 1996, Dr. Jacob, as a co-Founder of Genaera Corporation (formerly
Magainin Pharmaceuticals, Inc.) (a public biotechnology company), served
as Chief Operating Officer. From 1980 to 1988, Dr. Jacob was employed by
SmithKline and French Laboratories where he served as Worldwide Vice
President and a member of SmithKline Beecham's Corporate Management
Committee. Dr. Jacob serves as a Director of the Jacob Internet Fund (a
public mutual fund), Macromed Inc. (a private drug delivery company),
Carelift International (a non-profit medical relief organization),
Recording for the Blind and Dyslexic (a non-profit service organization
for the visual and learning disabled) and Saving Face (a non-profit
organization for facially disfigured children). Profile
company?
Dr. Jacob: InKine Pharmaceutical Company is a specialty pharmaceutical
company that currently serves the
